Stay updated on Pembrolizumab with CyBorD in NDMM Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with CyBorD in NDMM Clinical Trial page.

Latest updates to the Pembrolizumab with CyBorD in NDMM Clinical Trial page
- Check4 days agoChange DetectedRevision: v3.5.4 replaces the previous v3.5.3 in the page's history, indicating a new release of the record. This change updates the revision history without modifying the study details.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRecord History shows a new revision labeled v3.5.3, replacing the previous v3.5.2. This represents a minor update to the page's revision metadata rather than substantive changes to the study record.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedRevision v3.5.2 was added to the history. Revision v3.5.0 was removed from the history.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed from the record history.SummaryDifference0.1%

- Check69 days agoChange DetectedThe revision history now shows a new entry v3.4.3 and removes v3.4.2 from the record.SummaryDifference0.1%

- Check98 days agoChange DetectedRevision: v3.4.2 was added to the Record History. The deletions remove a government-funding notice and the earlier Revision: v3.4.1 from the history.SummaryDifference0.8%

Stay in the know with updates to Pembrolizumab with CyBorD in NDMM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with CyBorD in NDMM Clinical Trial page.